Copy number variation at 1q21.1 associated with neuroblastoma (original) (raw)

Nature volume 459, pages 987–991 (2009)Cite this article

Abstract

Common copy number variations (CNVs) represent a significant source of genetic diversity, yet their influence on phenotypic variability, including disease susceptibility, remains poorly understood. To address this problem in human cancer, we performed a genome-wide association study of CNVs in the childhood cancer neuroblastoma, a disease in which single nucleotide polymorphism variations are known to influence susceptibility1,2. We first genotyped 846 Caucasian neuroblastoma patients and 803 healthy Caucasian controls at ∼550,000 single nucleotide polymorphisms, and performed a CNV-based test for association. We then replicated significant observations in two independent sample sets comprised of a total of 595 cases and 3,357 controls. Here we describe the identification of a common CNV at chromosome 1q21.1 associated with neuroblastoma in the discovery set, which was confirmed in both replication sets. This CNV was validated by quantitative polymerase chain reaction, fluorescent in situ hybridization and analysis of matched tumour specimens, and was shown to be heritable in an independent set of 713 cancer-free parent–offspring trios. We identified a previously unknown transcript within the CNV that showed high sequence similarity to several neuroblastoma breakpoint family (NBPF) genes3,4 and represents a new member of this gene family (NBPF23). This transcript was preferentially expressed in fetal brain and fetal sympathetic nervous tissues, and the expression level was strictly correlated with CNV state in neuroblastoma cells. These data demonstrate that inherited copy number variation at 1q21.1 is associated with neuroblastoma and implicate a previously unknown neuroblastoma breakpoint family gene in early tumorigenesis of this childhood cancer.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Maris, J. M. et al. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. N. Engl. J. Med. 358, 2585–2593 (2008)
    Article CAS Google Scholar
  2. Capasso, M. et al. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nature Genet. 10.1038/ng.374 (3 May 2009)
  3. Vandepoele, K., Van Roy, N., Staes, K., Speleman, F. & Van Roy, F. A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution. Mol. Biol. Evol. 22, 2265–2274 (2005)
    Article CAS Google Scholar
  4. Vandepoele, K. et al. A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes. PLoS ONE 3, e2207 (2008)
    Article ADS Google Scholar
  5. Maris, J. M., Hogarty, M. D., Bagatell, R. & Cohn, S. L. Neuroblastoma. Lancet 369, 2106–2120 (2007)
    Article CAS Google Scholar
  6. Stranger, B. E. et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315, 848–853 (2007)
    Article ADS CAS Google Scholar
  7. Aitman, T. J. et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439, 851–855 (2006)
    Article ADS CAS Google Scholar
  8. Fanciulli, M. et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nature Genet. 39, 721–723 (2007)
    Article CAS Google Scholar
  9. Sebat, J. et al. Stong association of de novo copy number mutations with autism. Science 316, 445–449 (2007)
    Article ADS CAS Google Scholar
  10. Walsh, T. et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320, 539–543 (2008)
    Article ADS CAS Google Scholar
  11. Stone, J. L. et al. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455, 237–241 (2008)
    Article ADS CAS Google Scholar
  12. Stefansson, H. et al. Large recurrent microdeletions associated with schizophrenia. Nature 455, 232–236 (2008)
    Article ADS CAS Google Scholar
  13. Hollox, E. J. et al. Psoriasis is associated with increased b-defensin genomic copy number. Nature Genet. 40, 23–25 (2008)
    Article CAS Google Scholar
  14. Shlien, A. et al. Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome. Proc. Natl Acad. Sci. USA 105, 11264–11269 (2008)
    Article ADS CAS Google Scholar
  15. Steemers, F. J. et al. Whole-genome genotyping with the single-base extension assay. Nature Methods 3, 31–33 (2006)
    Article CAS Google Scholar
  16. Wang, K. et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 17, 1665–1674 (2007)
    Article CAS Google Scholar
  17. Conrad, D. F., Andrews, T. D., Carter, N., Hurles, M. & Pritchard, J. K. A high resolution survey of deletion polymorphisms in the human genome. Nature Genet. 38, 75–81 (2006)
    Article CAS Google Scholar
  18. Pinto, D., Marshall, C., Feuk, L. & Scherer, S. W. Copy-number variation in control population cohorts. Hum. Mol. Genet. 2, R168–R173 (2007)
    Article Google Scholar
  19. Zhang, Z., Schwartz, S., Wagner, L. & Miller, W. A greedy algorithm for aligning DNA sequences. J. Comput. Biol. 7, 203–214 (2000)
    Article CAS Google Scholar
  20. Popesco, M. C. et al. Human lineage-specific amplification, selection, and neuronal expression of DUF1220 domains. Science 313, 1304–1307 (2006)
    Article ADS CAS Google Scholar
  21. Mefford, H. C. et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N. Engl. J. Med. 359, 1685–1699 (2008)
    Article CAS Google Scholar
  22. Meza-Zepeda, L. A. et al. Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21. Oncogene 21, 2261–2269 (2002)
    Article CAS Google Scholar
  23. Petroziello, J. et al. Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancer. Oncogene 23, 7734–7745 (2004)
    Article CAS Google Scholar
  24. Diskin, S. J. et al. Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms. Nucleic Acids Res. 36, e126 (2008)
    Article Google Scholar
  25. Kent, W. J. BLAT — the BLAST-like alignment tool. Genome Res. 12, 656–664 (2002)
    Article CAS Google Scholar
  26. Brodeur, G. M. et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J. Clin. Oncol. 11, 1466–1477 (1993)
    Article CAS Google Scholar
  27. Shimada, H. et al. The international neuroblastoma pathology classification (the Shimada System). Cancer 86, 364–372 (1999)
    Article CAS Google Scholar
  28. Mathew, P. et al. Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study. Neoplasia 3, 105–109 (2001)
    Article CAS Google Scholar
  29. Look, A. T. et al. Clinical relevance of tumor cell ploidy and _N_-myc gene amplification in childhood neuroblastoma. A pediatric oncology group study. J. Clin. Oncol. 9, 581–591 (1991)
    Article CAS Google Scholar
  30. Gunderson, K. L., Steemers, F. J., Lee, G., Mendoza, L. G. & Chee, M. S. A genome-wide scalable SNP genotyping assay using microarray technology. Nature Genet. 37, 549–554 (2005)
    Article CAS Google Scholar
  31. Shaikh, T. H. et al. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum. Mol. Genet. 9, 489–501 (2000)
    Article CAS Google Scholar

Download references

Acknowledgements

The authors acknowledge the Children’s Oncology Group (U10-CA98543) for providing neuroblastoma specimens and thank the many children who participated in this study. This work was supported in part by NIH grants T32-HG000046 (S.J.D.), R01-CA87847 (J.M.M.) and R01-CA124709, GM081519 (T.H.S.), the Giulio D’Angio Endowed Chair (J.M.M.), the Alex’s Lemonade Stand Foundation (J.M.M.), the Evan Dunbar Foundation (J.M.M.), the Rally Foundation (J.M.M.), Andrew’s Army Foundation (J.M.M.), the Abramson Family Cancer Research Institute (J.M.M.), Howard Hughes Medical Institute Medical Research Training Fellowship (K.B.) and the Center for Applied Genomics (H.H.) at the Joseph Stokes Research Institute of the Children’s Hospital of Philadelphia.

Author Contributions S.J.D. and J.M.M. designed the study and drafted the manuscript. C.H., C.K. and H.H. performed the genotyping. S.J.D. analysed SNP data and performed the CNV association study. J.B., S.F.A.G., H.H. and H.L. performed the corrections for population stratification. S.J.D., E.F.A. and Y.P.M. analysed and interpreted SNP data for tumour specimens. K.W. and S.J.D. analysed SNP data for the second replication set. J.T.G. analysed SNP data from trios for inheritance estimates. C.H., S.J.D., A.W. and E.R.R. performed and/or analysed qPCR experiments. E.A.G., K.C. and T.H.S. performed FISH experiments. S.J.D., M.L., K.B., K.P., M.D. and E.R.R. designed and/or performed experiments to identify and sequence transcript within 1q21.1 CNV. J.E.L., C.W., S.J.D. and E.R.R. performed and/or analysed expression experiments. P.W.M. and W.B.L. analysed clinical covariates. A.I.F.B. provided detailed endpoints for 1q21.1 CNV in an independent analysis of healthy controls using a custom high-resolution Agilent array. M.D., H.L. and H.H. contributed to overall GWAS study design. All authors commented on or contributed to the current manuscript.

Author information

Authors and Affiliations

  1. Division of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia,
    Sharon J. Diskin, Cuiping Hou, Edward F. Attiyeh, Marci Laudenslager, Kristopher Bosse, Kristina Cole, Yaël P. Mossé, Andrew Wood, Jill E. Lynch, Katlyn Pecor, Maura Diamond, Cynthia Winter, Eric R. Rappaport & John M. Maris
  2. Genomics and Computational Biology, University of Pennsylvania School of Medicine,,
    Sharon J. Diskin
  3. The Center for Applied Genomics, Children’s Hospital of Philadelphia,,
    Cuiping Hou, Joseph T. Glessner, Kai Wang, Cecilia Kim, Jonathan Bradfield, Struan F. A. Grant & Hakon Hakonarson
  4. Department of Pediatrics, University of Pennsylvania School of Medicine,
    Edward F. Attiyeh, Yaël P. Mossé, Tamim H. Shaikh, Struan F. A. Grant, Marcella Devoto, Eric R. Rappaport, Hakon Hakonarson & John M. Maris
  5. Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine,,
    John M. Maris
  6. Division of Genetics, The Children’s Hospital of Philadelphia,
    Elizabeth A. Geiger, Tamim H. Shaikh, Struan F. A. Grant, Marcella Devoto & Hakon Hakonarson
  7. Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, 19104, USA,
    Hongzhe Li & Marcella Devoto
  8. Department of Statistics, University of Florida and Children’s Oncology Group, Gainesville, Florida, 32611, USA,
    Patrick W. McGrady & Wendy B. London
  9. Genomic Medicine, Imperial College London, London, SW7 2AZ, UK ,
    Alexandra I. F. Blakemore
  10. Department of Experimental Medicine, University of Rome “La Sapienza”, Rome, 00185, Italy,
    Marcella Devoto

Authors

  1. Sharon J. Diskin
    You can also search for this author inPubMed Google Scholar
  2. Cuiping Hou
    You can also search for this author inPubMed Google Scholar
  3. Joseph T. Glessner
    You can also search for this author inPubMed Google Scholar
  4. Edward F. Attiyeh
    You can also search for this author inPubMed Google Scholar
  5. Marci Laudenslager
    You can also search for this author inPubMed Google Scholar
  6. Kristopher Bosse
    You can also search for this author inPubMed Google Scholar
  7. Kristina Cole
    You can also search for this author inPubMed Google Scholar
  8. Yaël P. Mossé
    You can also search for this author inPubMed Google Scholar
  9. Andrew Wood
    You can also search for this author inPubMed Google Scholar
  10. Jill E. Lynch
    You can also search for this author inPubMed Google Scholar
  11. Katlyn Pecor
    You can also search for this author inPubMed Google Scholar
  12. Maura Diamond
    You can also search for this author inPubMed Google Scholar
  13. Cynthia Winter
    You can also search for this author inPubMed Google Scholar
  14. Kai Wang
    You can also search for this author inPubMed Google Scholar
  15. Cecilia Kim
    You can also search for this author inPubMed Google Scholar
  16. Elizabeth A. Geiger
    You can also search for this author inPubMed Google Scholar
  17. Patrick W. McGrady
    You can also search for this author inPubMed Google Scholar
  18. Alexandra I. F. Blakemore
    You can also search for this author inPubMed Google Scholar
  19. Wendy B. London
    You can also search for this author inPubMed Google Scholar
  20. Tamim H. Shaikh
    You can also search for this author inPubMed Google Scholar
  21. Jonathan Bradfield
    You can also search for this author inPubMed Google Scholar
  22. Struan F. A. Grant
    You can also search for this author inPubMed Google Scholar
  23. Hongzhe Li
    You can also search for this author inPubMed Google Scholar
  24. Marcella Devoto
    You can also search for this author inPubMed Google Scholar
  25. Eric R. Rappaport
    You can also search for this author inPubMed Google Scholar
  26. Hakon Hakonarson
    You can also search for this author inPubMed Google Scholar
  27. John M. Maris
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toJohn M. Maris.

Supplementary information

Supplementary Information

This file contains Supplementary Methods, Supplementary Tables 1-7 and Supplementary Figures 1-7 with Legends. (PDF 963 kb)

PowerPoint slides

Rights and permissions

About this article

Cite this article

Diskin, S., Hou, C., Glessner, J. et al. Copy number variation at 1q21.1 associated with neuroblastoma.Nature 459, 987–991 (2009). https://doi.org/10.1038/nature08035

Download citation

Editorial Summary

Copy number variation in neuroblastoma

Copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) are two important potential sources of phenotypic variation in humans. Until now, only SNPs have been associated with cancer, but the increasing recognition that germline DNA dosage is a critical component of human diversity raises the possibility that CNVs might also influence susceptibility to this cancer. Diskin et al. now report that a common CNV at chromosome 1q21.1 is associated with the childhood cancer neuroblastoma, and that a transcript within this CNV, the previously unknown neuroblastoma breakpoint family gene NBPF23, is involved in the early stages of tumorigenesis.